Skip to content
World Today News
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Technology
  • World
World Today News
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Technology
  • World
Friday, December 5, 2025
World Today News
World Today News
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Technology
  • World
Copyright 2021 - All Right Reserved
Home » Multiple sclerosis » Page 2
Tag:

Multiple sclerosis

Health

Gut Immune Cells Linked to Alzheimer’s Disease: New Therapeutic Pathway Found

by Dr. Michael Lee – Health Editor August 30, 2025
written by Dr. Michael Lee – Health Editor

Gut Health Intervention Shows Promise in Alleviating Alzheimer’s Symptoms in Mice

NOVATO, CA – August 30, 2025, 19:29:17 PDT – A new study from the Buck Institute for Research on Aging suggests a strong connection between gut health and the progression of Alzheimer’s disease (AD). Researchers discovered that supplementing the diet of mice with the pre-biotic fiber inulin led to improvements in AD-related frailty, including a reduction in tremors, and an overall extension of healthspan. The findings, published in Cell Reports, point to a bi-directional dialog pathway between the gut and the brain, offering potential new avenues for therapeutic intervention.

Alzheimer’s disease, a progressive neurodegenerative disorder, currently affects over 6.7 million americans, a number projected to rise dramatically as the population ages.While current treatments focus on managing symptoms, a cure remains elusive. This research highlights the potential of targeting the gut microbiome-the trillions of bacteria and other microorganisms residing in the digestive tract-as a novel approach to mitigating the disease’s impact. The study’s implications extend beyond AD, possibly informing strategies for other age-related neurological conditions where inflammation plays a key role. Researchers are now investigating whether gut changes are a result of brain alterations or a driving force behind the disease itself.

the research team, led by Dr.Dalip Winer, observed that mice genetically predisposed to develop AD exhibited changes in their gut immune systems. Specifically, migrating immune cells were depleted in the gut. Supplementation with inulin, a type of fiber found in foods like chicory root and onions, replenished these cells and reduced chemokine signaling in the brain. Chemokines are signaling molecules that attract immune cells, and elevated levels are often associated with inflammation.

“We found these migrating cells were replenished in the gut and that AD-related frailty, including the tremor trait, was reduced in the animals,” Dr. Winer stated. Inulin‘s beneficial effects are attributed to its production of short-chain fatty acids and other metabolites within the gut, which can then circulate throughout the body. The dietary intervention improved gut health and, consequently, reduced inflammation in the brain.

Interestingly,the high-fiber diet did not consistently reduce amyloid plaques-protein deposits considered a hallmark of AD-in the mice’s brains. However,the researchers found a significant advancement in overall well-being.An assay evaluating 31 aging metrics revealed that the inulin-supplemented diet extended the animals’ healthspan, enhancing their quality of life.

“We did an assay involving 31 metrics of aging in these mice. The diet definitely extended their healthspan, giving the animals a better quality of life,” Dr. Winer added. “this project supports the ‘eat your fruits and vegetables’ advice that is featured in nearly every dietary proposal.”

Researchers hypothesize that age-related factors may trigger inflammation in the brain, prompting the brain to signal the gut immune system for assistance. While this initial response may be protective, a compromised gut can lead to an overgrowth of harmful bacteria, exacerbating inflammation throughout the body.

“In the begining the process is likely protective,but over time the gut becomes compromised setting the stage for more dangerous types of bacteria to flourish which fuels inflammation throughout the body,” Dr. Winer explained.

Dr. Manisha Makhijani, a researcher involved in the study, emphasized the need for further examination into the gut microbiome’s role in neurological disease. “Maybe there is a microbiome that signals an increased risk of neurological disease. Perhaps we’ll be able to identify specific bacteria that set off immune system inflammation. What if we can inhibit the signaling chemokines early versus late in the disease process? Which woudl be protective for the whole system?” she said. “This paper provides so many avenues for further exploration.”

Source:

Buck Institute for Research on Aging

Journal reference:

Winer, D., et al. (2025) Amyloid-B driven Alzheimer’s disease reshapes the colonic immune system in mice. Cell Reports. DOI: 10.1016/j.celrep.2025.116109

August 30, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Multiple Sclerosis: New Insights into Inflammation and Neurodegeneration

by Dr. Michael Lee – Health Editor August 18, 2025
written by Dr. Michael Lee – Health Editor

Unlocking‍ New MS Therapies: Study Reveals ‌Key Link Between Inflammation ⁣and Neuronal Damage

Table of Contents

  • Unlocking‍ New MS Therapies: Study Reveals ‌Key Link Between Inflammation ⁣and Neuronal Damage
    • The Central Role of Inflammation in‍ Multiple Sclerosis
    • How Inflammation Drives ​Neuronal Cell Death
    • PFKFB3 Accumulation: A Key Pathological process
    • Potential for Novel⁣ MS Therapies
    • Study Details and Key⁣ Findings
    • Future Directions and Neuroprotective Strategies
      • Understanding ⁤the Landscape​ of Multiple Sclerosis
      • Frequently Asked Questions about Multiple Sclerosis

hamburg, Germany​ – A new study published in ‍the journal Cell offers a‍ strategic ⁣breakthrough in understanding the ‌complex ⁤mechanisms driving⁢ multiple sclerosis (MS). Researchers at the University Hospital ‌Hamburg-Eppendorf have pinpointed a precise connection between neuroinflammation and the degeneration of neurons, perhaps opening⁤ avenues for‌ innovative treatments. This research focuses‍ on the impact of ⁢inflammation on neuronal​ metabolism and identifies specific molecular targets for therapeutic intervention.

The Central Role of Inflammation in‍ Multiple Sclerosis

Multiple sclerosis is a chronic‍ inflammatory‍ disease⁤ of the central nervous system. ⁢the condition arises ⁣when the immune system mistakenly attacks myelin, ⁤the protective ‌sheath surrounding⁤ nerve fibers, disrupting ​communication between the brain‌ and the body [[2]].This⁢ immune‌ response triggers a cascade⁢ of inflammatory reactions and neurodegenerative processes,ultimately leading to neuronal ⁢damage.

A long-standing‌ challenge in MS research has ​been fully elucidating the ⁤relationship between chronic inflammation and the resulting neuronal harm.‍ This ⁢new study provides critical insights into this connection.

How Inflammation Drives ​Neuronal Cell Death

The research team,⁣ led by Woo ‌et al., demonstrated that neuroinflammation and ‍a disrupted neuronal metabolism contribute‍ to neuronal decline. Specifically, the study highlights the role of interferon-gamma (IFN-γ), a signaling ​molecule that⁢ modulates ‌the immune-proteasome-a complex responsible for protein homeostasis within⁢ nerve cells. Inhibition⁤ of protein reduction,‌ triggered by IFN-γ,‌ leads to ⁢oxidative stress ‌and, ultimately, ‍cell death.

Did You Know? Multiple sclerosis affects⁤ over 2.8 million people worldwide, with symptoms ‌varying widely‍ in severity ‌and presentation.

PFKFB3 Accumulation: A Key Pathological process

Using‍ advanced molecular, biochemical, ⁣and genetic techniques, the researchers identified a central‌ pathway driving this process:

  • IFN-γ induces Proteasom 20S ⁣Beta ‌8​ (PSMB8) expression in neurons.
  • The ‍incorporation of PSMB8 into⁣ the‌ immune proteasome impairs protein degradation within neurons.
  • This ⁤impairment leads to an accumulation of phosphofructo-2-kinase/fructose-2,6-biphosphatase 3⁢ (PFKFB3) within neurons.
  • Elevated PFKFB3 levels promote a metabolic shift toward increased glycolysis, reduced antioxidant capacity, and heightened susceptibility to ferroptosis-an iron-dependent form of programmed cell death.

Importantly, the study revealed‌ that ​PSMB8 expression is⁤ specifically pathological in neurons. Genetic deletion or‌ pharmacological ‌inhibition of PSMB8 significantly reduced neuronal degeneration.

Potential for Novel⁣ MS Therapies

These findings identify PSMB8 and ⁤PFKFB3 as promising therapeutic targets, operating independently of conventional immunomodulatory approaches.Given the limited efficacy of existing therapies ​in the chronic-progressive ‌phase of MS, modulating neuronal proteasome‌ activity​ could represent a groundbreaking approach. ⁣The ⁢researchers suggest further examination into the role‌ of these mechanisms in other neurodegenerative diseases, such ⁢as Alzheimer’s and Parkinson’s⁤ disease.

Pro Tip: Maintaining a healthy lifestyle, including regular exercise ​and​ a balanced diet, can ‌play​ a supportive⁣ role in‌ managing MS symptoms.

Study Details and Key⁣ Findings

Key Finding mechanism Implication
IFN-γ induces⁣ PSMB8 Modulates ⁤immune-proteasome activity Disrupts ​protein homeostasis
PFKFB3 Accumulation Metabolic⁤ shift towards‌ glycolysis Increases⁤ oxidative stress and ferroptosis
PSMB8 Inhibition reduces neuronal degeneration Potential therapeutic target

Future Directions and Neuroprotective Strategies

The study ‌by Woo et al. provides compelling evidence that inflammatory changes in neuronal proteasome composition-notably through PSMB8-are⁣ central ‍drivers of metabolic dysfunction and neurodegeneration in MS. The PFKFB3-dependent shift towards glycolysis ⁤exacerbates oxidative stress and ferroptosis. Targeting this ‌signaling pathway offers promising prospects for neuroprotective therapies in⁢ MS and​ potentially other‌ neurodegenerative conditions. What further research is ‍needed to‍ translate these findings into clinical applications? How ‍might these discoveries ‍impact ‌the long-term management of ‍MS for⁣ patients?

Understanding ⁤the Landscape​ of Multiple Sclerosis

Multiple sclerosis is an autoimmune ⁣disease affecting ​the brain ​and spinal ⁢cord.⁤ Symptoms can​ range from mild, such as numbness and fatigue, to severe, including ⁢paralysis. The disease course is unpredictable, with periods of remission and relapse. Current treatments focus on managing symptoms and slowing disease ⁢progression, but a cure remains elusive. Ongoing research is crucial⁢ to developing more effective therapies and ultimately preventing ‌the disease.

Frequently Asked Questions about Multiple Sclerosis

  • What is multiple sclerosis? MS is a chronic,often ​disabling‍ disease that affects the central nervous system.
  • What ⁤are the common symptoms of MS? Common symptoms include fatigue,‍ difficulty walking, ⁣numbness, and‌ vision problems.
  • Is ther ⁣a cure for multiple sclerosis? Currently, there ⁢is ‍no​ cure ‌for MS, but treatments ⁣can ‌definitely help manage symptoms and slow disease progression.
  • What causes multiple sclerosis? The exact cause of MS is unknown, but it⁢ is ⁣believed to be⁤ a combination of genetic and environmental factors.
  • How is multiple sclerosis diagnosed? Diagnosis typically⁤ involves a ⁤neurological exam, MRI scans, and‍ sometimes a spinal ⁢tap.

Disclaimer: This article provides⁤ general data and⁢ should not be considered medical advice. Please consult with a⁣ qualified healthcare professional for any health concerns or ⁣before​ making any decisions related to⁣ your health or treatment.

we hope this ‍article‌ has provided valuable insights into ⁣the latest research⁣ on multiple sclerosis.Share this information with your‍ network to raise awareness and support ongoing research efforts. Subscribe to our‍ newsletter for more breaking ​news and ⁤in-depth analysis on health and ‌science.

August 18, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Multiple Sclerosis: A Blood Test to Prevent Disability

by Chief editor of world-today-news.com September 23, 2024
written by Chief editor of world-today-news.com

A simple blood test could revolutionize healthcare for patients affected by multiple sclerosis and prevent disability, according to a recent study.

This test would allow prediction of disease progression and treatment effectiveness, especially by detecting signs of nerve damage in the patient’s blood.

Multiple sclerosis, or multiple sclerosis, which affects the brain and spinal cord, is characterized by:

  • muscle weakness or paralysis,
  • visual disturbances,
  • problems with balance,
  • coordination problems,
  • vertigo,
  • memory problems,
  • severe fatigue.

According to the International Multiple Sclerosis Federation, the risk of the disease is higher in people who have relatives with this condition.

Risk factors for multiple sclerosis include:

  • age: this disease is more common in people between 20 and 40;
  • gender: women are more exposed;
  • viral infections with Epstein Barr;
  • lack of vitamin D;
  • the presence of autoimmune diseases: psoriasis, diabetes type 1, pernicious anemia.

This neurodegenerative disease, of an autoimmune type, is associated with many COMBINEDthere are two main types of manifestation: the relapsing form, characterized by pustules followed by relief, and the progressive form, in which the symptoms get worse without stopping.

The study of this blood test was presented at the recent European Congress for Treatment and Research in Multiple Sclerosis in Copenhagen.

The researchers found that patients with high levels of a protein that indicates nerve damage were 45 percent more likely to suffer a relapse.

With the help of this trial, better targeted treatments could be given to patients at higher risk, which would improve their care and delay the progression of the disease.

The results of this study reinforce the real need for personalized treatment methods,” said Dr. Enric Monreal, multiple sclerosis specialist in Madrid and author of the study.

Multiple sclerosis treatment is symptomatic and aims to improve the patient’s quality of life by reducing the intensity, duration and frequency of clinical manifestations.

2024-09-23 04:55:00
#Multiple #Sclerosis #Blood #Test #Prevent #Disability

September 23, 2024 0 comments
0 FacebookTwitterPinterestEmail
Christina Applegate suffers from extreme despair
World

Christina Applegate suffers from extreme despair

by Chief editor of world-today-news.com June 5, 2024
written by Chief editor of world-today-news.com

Christina Applegate In August 2021, he introduced that he had been identified with a number of sclerosis that yr. The The legend of the well-known Ron Burgundythat’s A very nice household is in You might be useless its star has since given up his profession and mentioned final yr that he in all probability will not be in entrance of the digicam once more. This yr, nonetheless, he had public appearances, began giving interviews, however in March, for instance, he talked about residing in a type of hell. Now the Messy podcast was a visitor of his, the place he mentioned that not too long ago he has been overcome by extreme despair, which frightens even him together with his concentrated fatalism.

I used to be trapped on this darkness, one thing I hadn’t felt in about twenty years. (…) I do not take pleasure in life, I simply do not. I do not take pleasure in issues anymore

– Applegate mentioned, including that resulting from his psychological struggles, he additionally made an appointment with a therapist, which he considers an enormous breakthrough on his half. Beforehand, she averted remedy as a result of she felt that if tears began to circulate, she can be unable to cease crying.

In January, Applegate additionally appeared on stage on the Emmys to current an award. The viewers gave him a standing ovation, and he was visibly moved by the cordial response.

June 5, 2024 0 comments
0 FacebookTwitterPinterestEmail
Merz Therapeutics to Acquire Two Drugs from Acorda Therapeutics in $185 Million Deal
Business

Merz Therapeutics to Acquire Two Drugs from Acorda Therapeutics in $185 Million Deal

by Chief editor of world-today-news.com April 3, 2024
written by Chief editor of world-today-news.com

Merz Therapeutics GmbH, a subsidiary of the Merz Group (Frankfurt/Main), signed an agreement to acquire two marketed drugs from the NASDAQ-listed US company Acorda Therapeutics. The completion of the transaction will “significantly contribute to Merz Therapeutics’ accelerated growth strategy,” the company said. It is the second investment in a NASDAQ company in just over ten years.

The acquisition is expected to take place as part of a court-structured sales process under the US Bankruptcy Code, with Merz Therapeutics having submitted the opening bid in the potential auction. The purchase price offered by Merz is $185 million. The sales process is expected to be completed in June 2024. The sale is subject to court approval. The final price can also change further down the line.

“Our company Merz Therapeutics, which specializes in neurology, has developed very well in recent years. The intended investment fits perfectly into Merz Therapeutics’ further growth strategy, as it expands the existing portfolio in the area of ​​movement disorders and neurodegeneration and strengthens the market position in North America,” says Jörg Bergler, COO of the Merz Group. “We are very pleased about the development of Merz Therapeutics and are convinced that the acquisition of the two drugs – one for the treatment of the OFF phase of Parkinson’s disease and one for the treatment of gait disorders in multiple sclerosis – will be of great benefit to doctors and patients will be significant.”

For the Merz family business, this investment in a US company would be the third in just over ten years and the second in a company listed on the NASDAQ. “Merz has grown significantly in recent years – organically, but also through strategic acquisitions, especially in North America. We therefore have in-depth experience in both the acquisition and integration of companies or products. As a German but global company, we are very interested in innovative acquisitions, especially in North America,” says Bergler. Stefan König, CEO of Merz Therapeutics, adds: “We see an optimal potential portfolio expansion here, which underlines our ambitions in important therapeutic areas.”

The story of Acorda Therapeutics is not one of success. Ampyra, the drug used to treat walking problems in patients with multiple sclerosis, generated $63.9 million in U.S. sales last year, well below its peak sales of $543 million in 2017. At the time, the drug still seemed to be the company’s hope, but a patent dispute led to the loss of important marketing opportunities and a massive wave of layoffs. The second drug acquired by Merz is also not going well. Inbrija (Parkinson) brought sales of $38.4 million in 2023, but its marketing partner Biogen recently returned the rights to the company, which then had to lay off employees again and ultimately only saw salvation in bankruptcy proceedings.

Merz has been family-owned for 116 years. The Merz Group includes the businesses Merz Aesthetics, Merz Therapeutics, Merz Consumer Care, Merz Immobilien and Merz Financial Investments. The company employs 4,337 people. Merz Therapeutics is represented and active in around 90 countries. It remains to be seen whether Merz is already right with his offer or whether other interested parties will come forward and a bidding war will break out for Acorda’s two assets. Likewise, the question of whether Merz has caught a few bargains will only be able to be answered in some time, as the greater marketing success of the drugs in the USA under a Merz flag is not guaranteed.

2024-04-03 21:18:28
#Merz #buys #biotech #company #Acorda

April 3, 2024 0 comments
0 FacebookTwitterPinterestEmail
How household products are linked to multiple sclerosis and autism
 – 2024-03-29 04:40:08
Technology

How household products are linked to multiple sclerosis and autism – 2024-03-29 04:40:08

by Chief editor of world-today-news.com March 29, 2024
written by Chief editor of world-today-news.com

Researchers at the Case Western Reserve University School of Medicine in Ohio, USA, are “sounding the alarm” about the harmful effect that everyday chemicals have on the health of the human brain.

According to their study published in the scientific journal “Nature Neuroscience”, chemicals contained in many products and objects we have in our homes – from furniture and electronic devices to disinfectants and hair care products – are possibly linked to serious neurological diseases such as multiple sclerosis and autism spectrum disorders.

The role of the environment

Millions of people suffer from neurological disorders worldwide, yet only a percentage of neurological cases are attributed solely to genetic causes. This fact testifies that environmental factors probably also contribute significantly to the occurrence of different neurological diseases.

“Wound” in oligodendrocytes

According to the new study, common everyday chemicals have a negative effect on oligodendrocytes, specialized brain cells that create the protective “insulation” that surrounds nerve cells – this “sheath” is vital for their proper functioning.

Link to neurological disorders

“Loss of brain oligodendrocytes is associated with the onset of multiple sclerosis and other neurological disorders,” noted the new study’s principal investigator, Paul Tezar, Professor of Innovative Therapeutics and director of the Institute for Glial Sciences at Case Western Reserve University, and added: “We showed now that certain chemicals contained in consumer products can directly damage oligodendrocytes, constituting a previously unknown risk factor for neurological disorders.”

The two “guilty” categories of chemicals

In order to reach their conclusions, the researchers analyzed more than 1,800 chemicals that humans are exposed to. They found that the chemicals that selectively destroy oligodendrocytes fall into two categories: organophosphate flame retardants (OPFRs) and quaternary ammonium compounds (QACs).

Given that QACs are contained in many personal hygiene products as well as disinfectants, which are now used much more frequently after the COVID-19 pandemic, people are exposed to these chemicals on a regular basis. At the same time, many electronic devices as well as furniture contain OPFRs, with the result that the population has daily contact with them.

Experiments in the laboratory and on mice

The scientists used cell systems as well as organelles in the laboratory to show that QACs drive oligodendrocytes to die while OPFRs prevent these cells from maturing. They then showed in mice that both classes of chemicals destroy oligodendrocytes in the developing rodent brain. They also linked exposure to one of the chemicals to “poor” neurological development in children.

The “missing environmental link” of neurological diseases

“We found that oligodendrocytes – but not other brain cells – are surprisingly vulnerable to both OPFRs and QACs,” said Erin Kohn, lead author of the new study and a graduate student in the Medical Science Education Program at Case University School of Medicine. Western Reserve and added: “Understanding human exposure to these chemicals may provide an explanation for the ‘missing link’ in the development of certain neurological diseases.”

Regulatory measures and behavioral interventions

According to the researchers, further research is now needed to establish the link between human exposure to the chemicals and their effect on brain health. Future research should focus on identifying the levels of the chemicals in the brains of adults and children in order to determine the duration and levels of exposure that are detrimental to health.

“We hope that our research work will contribute to informed decision-making by the authorities regarding regulatory measures as well as behavioral interventions in order to reduce the population’s exposure to chemicals and protect human health,” concluded Professor Tezar.

#household #products #linked #multiple #sclerosis #autism

March 29, 2024 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Search:

Recent Posts

  • Labor closes the negotiation with CEOE on death permits and will take it to Congress only with the unions

    December 5, 2025
  • Here’s the Best Travel-Friendly Gifts For Every Budget This Holiday Season

    December 5, 2025
  • Arkansas Jail Sees Surge in ICE Arrests Amidst New Laws and Agreements

    December 5, 2025
  • Title: Spencer Knight Set to Start vs. Kings

    December 5, 2025
  • Title: #STATEtoSundays: Week 14 NFL Alumni Preview

    December 5, 2025

Follow Me

Follow Me
  • Live News Feeds
  • Short Important News
  • Most Important News
  • Headlinez
  • Most Recommended Web Hosting
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Copyright Notice
  • Disclaimer
  • DMCA Policy
  • EDITORIAL TEAM
  • Links
  • Privacy Policy
  • Terms & Conditions

@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com


Back To Top
World Today News
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Technology
  • World
World Today News
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Technology
  • World
@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com